Modulation of apoptosis: new opportunities for drug discovery to treat autoimmune thyroiditis

Yujiang Fang1, Lei Zhao, Charles A Parker

  • 1Department of Internal Medicine, University of Missouri, Missouri 65212, USA. fangy@health.missouri.edu

Insights

The balance of cell death (apoptosis) and growth (proliferation) is crucial in autoimmune thyroiditis. Molecules regulating apoptosis in thyroid cells and lymphocytes significantly impact this disease, with emerging therapeutic targets.

Area of Science:

  • Immunology
  • Pathology
  • Endocrinology

Background:

  • The pathogenesis of autoimmune thyroiditis is significantly influenced by the balance between apoptosis and cell proliferation.
  • Pro- and anti-apoptotic molecules in thyroid epithelial cells and infiltrating lymphocytes are recognized as key players in autoimmune thyroiditis.
  • Understanding these molecular mechanisms is vital for disease management.

Purpose of the Study:

  • To review the role of apoptosis in the pathogenesis of autoimmune thyroiditis.
  • To discuss findings from experimental autoimmune thyroiditis (EAT) and iodine-induced autoimmune thyroiditis (IAT) murine models.
  • To highlight recent patents on apoptosis-targeting therapies for autoimmune thyroiditis.

Main Methods:

  • Literature review focusing on apoptosis in autoimmune thyroiditis.
  • Analysis of data from established murine models (EAT and IAT).
  • Examination of recent patent literature concerning therapeutic strategies.

Main Results:

  • Apoptosis plays a critical role in the development and progression of autoimmune thyroiditis.
  • Specific pro- and anti-apoptotic molecules are implicated in thyroid epithelial cells and lymphocytes.
  • Several patents indicate novel therapeutic avenues targeting apoptotic pathways.

Conclusions:

  • The regulation of apoptosis is central to the pathogenesis of autoimmune thyroiditis.
  • Targeting apoptotic pathways represents a promising therapeutic strategy.
  • Further clinical trials are necessary to validate the efficacy and safety of these novel agents.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...